AMPH

AMPHASTAR PHARMACEUTICALS IN

AMPH·03209R103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

AMPH (AMPHASTAR PHARMACEUTICALS IN) is held by 118 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($106.2M), DIMENSIONAL FUND ADVISORS LP ($39.7M), STATE STREET CORP ($31.5M). Net institutional sentiment: Mixed.

118
Holders
Avg rating(27 Elite)
$563.9M
Total Value
44% (139)
Fund Consensus
58 buying - 73 selling
AMPHSmart Money Verdict
View all
Held by 118 funds
27 elite
Who's Trading
ActivistDimensional Fund Advisors LPDimensional Fund Advisors LP5.2%Jul 14, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderZRZhou RongSell $256KDec 17, 2025
InsiderPFPetersen Floyd F.Sell $63KDec 12, 2025
InsiderPFPetersen Floyd F.Sell $45KDec 11, 2025
InsiderPKPRINS RICHARD KSell $113KNov 25, 2025
InsiderPFPetersen Floyd F.Sell $442KNov 13, 2025
ActivistBlackRock, Inc.BlackRock, Inc.11.5%Oct 17, 2025
InsiderPFPetersen Floyd F.Sell $14KOct 1, 2025
InsiderPFPetersen Floyd F.Sell $15KSep 2, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
5.4M(-0.7%)$106.2M0.0%-49.13%
0
Increased
2M(+12.7%)$39.7M0.0%-41.90%
33
Increased
1.6M(+4.9%)$31.5M0.0%-67.40%
30
New
1.5M$30.2M0.0%-5.60%
40
Decreased
1.5M(-21.5%)$30.2M0.0%-59.17%
0
Increased
1.4M(+0.1%)$27.3M0.1%-49.36%
29
Decreased
1M(-17.1%)$20.1M0.0%-45.58%
0
Increased
1M(+52.9%)$19.9M0.0%-34.70%
40
Increased
976,650(+10.1%)$19.1M0.0%-26.22%
31
Decreased
944,789(-13.1%)$18.5M0.2%-53.39%
0
Decreased
898,895(-20.2%)$17.6M0.1%-61.56%
0
New
787,816$15.4M0.0%-5.60%
39
Increased
665,542(+19.5%)$13M0.0%-24.44%
33
Increased
604,774(+20.6%)$11.8M0.0%-23.32%
33
Increased
553,900(+1.7%)$10.9M0.0%-38.05%
28
Decreased
420,337(-28.9%)$8.2M0.0%-48.55%
0
Increased
420,263(+63.8%)$8.2M0.0%-29.31%
40
Increased
406,175(+15.3%)$8M0.1%-30.12%
32
Increased
372,279(+0.2%)$7.3M0.0%-34.70%
27
Increased
371,373(+27.8%)$7.3M0.0%-35.16%
34

Showing 1-20 of 139

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used